Innovations in science and technology are leading to rapid developments in biosimilar medicines, with the potential to bring lower-cost treatments to more people.
How innovations by Samsung Bioepis are meeting demand for affordable health care
  • Science and technology are driving innovations to increase patient access to cost-effective treatments
  • Amid the pandemic, strategic positioning of manufacturing and storage sites allowed Samsung Bioepis to respond quickly to market dynamics